WebOct 7, 2024 · BURLINGTON, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the … WebOperating Status Active. Last Funding Type Post-IPO Equity. Legal Name scPharmaceuticals, Inc. Stock Symbol NASDAQ:SCPH. Company Type For Profit. Contact Email [email protected]. Phone Number (617)517-0730. ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously …
Dori Capretti - Vice President, Ma.. - scPharmaceuticals ZoomInfo
http://ir.scpharma.com/presentations WebDec 7, 2024 · Why It's Important: scPharma's original NDA was issued a CRL in 2024, wherein the agency sought additional human factor studies, device modifications and … mistral coffee table
James DellaGatta Email & Phone Number - scPharm.. ZoomInfo
WebLearn more about FUROSCIX ® including Full Prescribing Information and important safety information. Click here to see our patent portfolio. Products, Research & Development. FUROSCIX® (furosemide injection) 80mg/10mL for subcutaneous use. scCeftriaxone. WebAbout FUROSCIX ® (furosemide injection) for subcutaneous injection . FUROSCIX is an investigational, proprietary furosemide solution formulated to a neutral pH, designed to allow for subcutaneous infusion via a wearable, pre-programmed on-body drug delivery system, for outpatient self-administration. FUROSCIX is currently under development for the … http://ir.scpharma.com/news-releases mistral coffee machine matte black